Biocoat is a medical device company that specializes in supplying hydrophilic coatings and dip coating equipment. Founded in 1991, the company develops and licenses biomaterial coatings custom engineered to meet client design parameters. The core focus of Biocoat is its lubricious hydrophilic coatings for medical devices, renowned for their industry-leading performance. The company's flagship product, HYDAK® Hydrophilic Coating, offers a range of advantages including exceptional hydrophilicity, lubricity when wet to prevent trauma and tissue abrasion, abrasion resistance, and biocompatibility. Additionally, the coating prevents adhesion of platelets, proteins, and microorganisms, making it a carrier for bioactive substances to create anti-bacterial and anti-thrombogenic surfaces.
It's worth noting that there's no specific information available regarding the company's headquarters, last investment, or the investors involved in the last investment round.